Neuropsychological changes in efavirenz switch regimens.

Area of Science:

• Neuroscience
• HIV/AIDS Research
• Pharmacology

Background:

• Efavirenz (EFV) is linked to central nervous system side effects.
• The impact of discontinuing EFV on neuropsychological function is not well understood.

Purpose of the Study:

• To investigate whether discontinuing Efavirenz (EFV) improves neuropsychological performance.
• To assess changes in depression severity after EFV discontinuation.

Main Methods:

• Utilized data from the Multicenter AIDS Cohort Study (MACS).
• Categorized participants into: never on EFV, continuously on EFV, or switched off EFV.
• Compared neuropsychological and depression scores before and after EFV switch, and analyzed trajectories across groups.

Main Results:

• Included 1989 HIV-seropositive participants.
• No clinically significant changes in neuropsychological or depression scores were observed after EFV switch.
• No significant differences in neuropsychological or depression score trends were found among the three EFV use groups.

Conclusions:

• Discontinuing Efavirenz (EFV) is not associated with improved neuropsychological performance or reduced depression in men.
• No differences in outcomes were observed between participants who never used EFV, continuously used EFV, or discontinued EFV.